Mehta Vimal 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Mehta Vimal（CIK 1733369）在 1 家公司共报告 13 笔 SEC Form 4 内部人交易（最近一笔 2026-06-17）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-17 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | 买入 | 219 | $0 |
| 2026-05-22 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | 买入 | 49,758 | $0 |
| 2026-05-22 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | 卖出 | 19,419 | $21,167 |
| 2026-05-07 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | 买入 | 18,000 | $0 |
| 2026-03-16 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | 买入 | 164 | $0 |
| 2026-03-16 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | 买入 | 219 | $0 |
| 2025-12-15 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | 买入 | 164 | $0 |
| 2025-12-15 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | 买入 | 219 | $0 |
| 2025-09-16 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | 买入 | 163 | $0 |
| 2025-09-16 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | 买入 | 219 | $0 |
| 2025-07-22 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | 买入 | 15,625 | $0 |
| 2025-06-16 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | 买入 | 163 | $0 |
| 2025-06-16 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | 买入 | 219 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-06-17